In patients with T2DM, decreased muscle mass leads to deteriorated insulin sensitivity, aggravated diabetes (18), increased somatostatin secretion, abnormal bone metabolism, and reduced bone mass, and is associated with osteoporosis (19). This evidence concerns the gene INS and type 2 diabetes mellitus.